# Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)

> **NCT00211445** · PHASE2 · COMPLETED · sponsor: **Manhattan Eye, Ear & Throat Hospital** · enrollment: 11 (actual)

## Conditions studied

- Chronic Central Serous Chorioretinopathy

## Interventions

- **PROCEDURE:** Photodynamic Therapy with Verteporfin
- **DRUG:** verteporfin

## Key facts

- **NCT ID:** NCT00211445
- **Lead sponsor:** Manhattan Eye, Ear & Throat Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-07
- **Primary completion:** —
- **Final completion:** 2006-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2007-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00211445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00211445, "Photodynamic Therapy Using Verteporfin for Treatment of Chronic Central Serous Chorioretinopathy (CSC)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00211445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*